Reasons to invest
Reason No. 4: We have an attractive portfolio of products, biotechnology solutions and processes
- We possess extensive and well-founded knowledge concerning enzymes, microorganisms, cell-based test systems, and bioactive natural compounds. An interdisciplinary approach enables us to conceive and develop completely new products and services for our customers.
- We do not limit ourselves to individual technologies and methods, but instead leverage our broad technology portfolio.
- Bioinformatics forms a central element of our R&D expertise for faster and better solutions. In addition to our employees’ experience, we rely here on state-of-the-art technologies in the machine learning and artificial intelligence areas.
- The targeted modification and programming of cells is one of BRAIN Biotech’s core competencies. In this context, we deploy all commercially available technologies as well as our proprietary nucleases G-dase M® and G-dase E® for genome editing.
- We are an expert solution provider for industry – from research and the scaling up of industrial biological processes to the production of enzymes and proteins.
- More than thirty years of experience, around 600 available products for our B2B customers, and over 200 successfully completed industrial cooperation projects are strong testimony to our success.